For the Inventor, By the Inventor

Enter assignee name

Villejuif, France

Institut Gustave Roussy

USPTO Granted Patents = 101

% Expired Patents = 29.7

CIPO Patents = 7

EPO Patents = 63

Trademarks = 2

Forward Citations = 488

Loading Chart...

Loading Chart...

228 inventors (with patents filed for the assignee):

Laurence Zitvogel (21 out of 24 patents)

William Vainchenker (11 out of 13 patents)

Guido Kroemer (9 out of 17 patents)

4. Eric Deutsch (8 out of 10 patents)

5. Thierry Heidmann (8 out of 11 patents)

6. Nicole Casadevall (6 out of 7 patents)

7. Frederic Triebel (6 out of 26 patents)

8. Jean-Pierre Le Couedic (5 out of 6 patents)

9. Jean-Luc Perfettini (5 out of 5 patents)

10. Didier Desmaele (5 out of 9 patents)

11. Thierry Hercend (5 out of 17 patents)

12. Mouad Alami (4 out of 11 patents)

13. Franck Viguie (4 out of 4 patents)

14. Olivier Bernard (4 out of 8 patents)

15. Michaela Fontenay (4 out of 6 patents)

Core Competencies:

Cancer Therapy

Immunotherapy

Biomarkers

Tumor Growth

Colorectal Cancer

Microbiota Composition

Cancer Prognosis

Oncolytic Virus

Hematopoietic Neoplasms

Cancer Chemotherapy

Regulatory T Lymphocytes

Tumor Sensitization

101 patents: Sort by Forward Citations

1. 12644156 - Methods for diagnosing, prognosing and managing treatment of breast cancer (2026-06-02),

2. 12622937 - Combination of oncolytic virus with immune checkpoint modulators (2026-05-12),

3. 12551515 - METHODS AND COMPOSITIONS FOR TREATING CANCER (2026-02-17),

4. 12516125 - Antibody which is Directed Against Galectin-9 and is an Inhibitor of the Suppressor Activity of Regulatory T Lymphocytes (2026-01-06),

5. 12514902 - P21 Expressing Monocytes for Cancer Cell Therapy (2026-01-06),

6. 12511747 - Method for training a decision system for segmenting medical images (2025-12-30),

7. 12458594 - Injectable water-in-oil emulsions and uses thereof (2025-11-04),

8. 12371417 - Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties (2025-07-29),

9. 12246044 - Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same (2025-03-11),

10. 12213978 - Madrasin-derivative compounds, composition and uses thereof for treating cancer (2025-02-04),

11. 12144839 - Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 AB-based treatment (2024-11-19),

12. 12102672 - Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer (2024-10-01),

13. 11957868 - Means for transporting persons with reduced mobility comprising a device with for connecting to aserum holder, associated connecting assembly (2024-04-16),

14. 11732303 - Prognostic marker for myeloproliferative neoplasms (2023-08-22),

15. 11730732 - Oral suspension of temozolomide (2023-08-22),

Company Overview

Institut Gustave Roussy, located in Villejuif, France, is a leading cancer treatment and research center dedicated to advancing oncology. The institute specializes in various domains, including cancer therapy, immunotherapy, and the study of biomarkers related to tumor growth and prognosis. Its research initiatives focus on understanding colorectal cancer and the role of microbiota composition in cancer progression. By integrating clinical practice with innovative research, Institut Gustave Roussy aims to improve patient outcomes and contribute to the global fight against cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

101 Patents

#1 in Villejuif

#270 in France

#7,721 in the World

Villejuif, France

Institut Gustave Roussy

Forward Citations = 488

228 inventors:

Laurence Zitvogel (21 out of 24 patents)

William Vainchenker (11 out of 13 patents)

Guido Kroemer (9 out of 17 patents)

4. Eric Deutsch (8 out of 10 patents)

5. Thierry Heidmann (8 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Institut Gustave Roussy. Retrieved from https://idiyas.com/company/institut-gustave-roussy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…